drugset / Trial / NCT00420043
Effect of Food on Bioavailability of Modified Release Formulations of Imatinib
RandomizedCrossoverOpen-labelTreatment
Summary
This study will evaluate the effect of food on the relative bioavailability of a single dose of imatinib given as a 800 mg modified release tablet, compared to twice-daily doses of 400 mg film-coated tablets. There will be a 8 day wash out phase between treatments and a 1 week safety period at the end of the study. Each participant will receive all four treatments.
Timeline
- Start
- 2006-09
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imatinib | Small molecule | 400 mg | — |
| Subject | Imatinib | Small molecule | 800 mg | — |
Indications
No indication recorded.